GEMINI PHARMCHEM
DEAD

Serial Number

79143952

Owner

Gemini PharmChem Mannheim GmbH

Attorney

Rachel Rudensky

Filing Date

Nov 26, 2013

Add to watchlist:

No watchlists yet
View on USPTO

GEMINI PHARMCHEM Trademark

Serial Number: 79143952

GEMINI PHARMCHEM is a trademark filed by Gemini PharmChem Mannheim GmbH on November 26, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Gemini PharmChem Mannheim GmbH (2 trademarks)

Sandhofer Straße 96

Entity Type: 99

Trademark Details

Filing Date

November 26, 2013

Registration Date

Not Registered

Published for Opposition

June 23, 2015

Goods & Services

PHARMACEUTICAL AND VETERINARY PREPARATIONS FOR TREATING VARIOUS TYPES OF CANCERS, DISEASES OF THE IMMUNOLOGICAL SYSTEM, NAMELY, AUTO-IMMUNE DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, AND FOR PREVENTION OF ORGAN REJECTION AFTER TRANSPLANTATION, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL PREPARATIONS FOR PHARMACEUTICAL USE, NAMELY, FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY USE; PHARMACEUTICAL PREPARATIONS FOR MEDICAL USE FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY; ANTIBIOTICS; DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS; RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE; ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS

BUSINESS MANAGEMENT SERVICES, NAMELY, REGULATORY SUBMISSION MANAGEMENT, NAMELY, ASSISTING OTHERS IN PREPARING AND FILING APPLICATIONS FOR DRUGS WITH GOVERNMENTAL REGULATORY BODIES; all of the aforementioned services only in relation to pharmaceuticals and chemicals; RETAIL SERVICES, NAMELY, RETAIL STORE SERVICES, MAIL ORDER SERVICES AND ON-LINE RETAIL STORE SERVICES FEATURING ACTIVE PHARMACEUTICAL INGREDIENTS, AND VETERINARY PREPARATIONS, CHEMICAL PREPARATIONS FOR PHARMACEUTICAL PURPOSES, PHARMACEUTICAL PREPARATIONS FOR MEDICAL PURPOSES, DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS, RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE; all of the aforementioned services only in relation to pharmaceuticals and chemicals

CHEMICALS FOR USE IN INDUSTRY AND SCIENCE, NAMELY, CHEMICAL PREPARATIONS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, ACTIVE PHARMACEUTICAL INGREDIENTS FOR THE MANUFACTURE OF FINISHED PHARMACEUTICALS, ACTIVE CHEMICAL INGREDIENTS AND AGENTS FOR USE IN THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, PHARMACEUTICALS, ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS; PRESERVATIVES FOR PHARMACEUTICAL PREPARATIONS

scientific and technological services, namely, research, design, evaluations and engineering appraisals in the fields of chemical intermediates, active chemical ingredients provided by engineers and scientists; industrial analysis and research services in the field of chemical intermediates and active chemical ingredients; engineering; research in the field of chemical research; chemical analysis; chemistry services, namely, chemistry consultation, research in the field of chemistry, optimization of chemical processes, analysis for polymorphism determination; biological research; bacteriological research; physics research; chemical research; all of the aforementioned services only in relation to pharmaceuticals and chemicals

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 17, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jun 17, 2024 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 31, 2018 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 3, 2018 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2018 FICR
ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Aug 3, 2017 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Aug 3, 2017 ABN4
OPPOSITION TERMINATED NO. 999999
Aug 3, 2017 OP.T
OPPOSITION SUSTAINED NO. 999999
Aug 3, 2017 OP.S
REFUSAL PROCESSED BY IB
Nov 8, 2015 RFNT
OPPOSITION INSTITUTED NO. 999999
Oct 19, 2015 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Oct 16, 2015 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Oct 16, 2015 OPNC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 11, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 26, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 26, 2015 OPNR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Aug 3, 2015 LIME
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 23, 2015 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jun 20, 2015 GPNX
LIMITATION OF GOODS RECEIVED FROM IB
Jun 19, 2015 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 3, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2015 PREV
EXPARTE APPEAL TERMINATED
May 8, 2015 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2015 CNEA
ASSIGNED TO EXAMINER
May 8, 2015 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2015 CRFA
ASSIGNED TO LIE
Apr 22, 2015 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 20, 2015 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 20, 2015 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 20, 2015 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 20, 2015 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 27, 2014 GNFN
FINAL REFUSAL E-MAILED
Oct 27, 2014 GNFR
FINAL REFUSAL WRITTEN
Oct 27, 2014 CNFR
ASSIGNED TO EXAMINER
Oct 6, 2014 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2014 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 26, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 26, 2014 REAP
REFUSAL PROCESSED BY IB
Apr 18, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
Apr 1, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 25, 2014 MAFR
ASSIGNED TO EXAMINER
Mar 21, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 20, 2014 REPR